We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-16.97%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.02B
AUM Growth
-$307M
Cap. Flow
-$225M
Cap. Flow %
-2.49%
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20

Top Buys

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$11.3M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.97M
3
IVZ icon
Invesco
IVZ
+$1.15M
4
MSFT icon
Microsoft
MSFT
+$13.8K
5
AAPL icon
Apple
AAPL
+$12.4K

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.5M
3
INST
Instructure, Inc.
INST
+$9.03M
4
DERM
Dermira, Inc.
DERM
+$8.64M
5
EQH icon
Equitable Holdings
EQH
+$7.36M

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Technology 19.71%
3 Financials 10.21%
4 Consumer Discretionary 9.38%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$335M 3.71%
2,172,980
+84
+0% +$13.8K
AMGN icon
2
Amgen
AMGN
$199B
$213M 2.36%
904,968
+20
+0% +$4.37K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.88T
$208M 2.31%
3,184,020
+120
+0% +$8.13K
AAPL icon
4
Apple
AAPL
$4.7T
$197M 2.18%
2,740,884
+168
+0% +$12.4K
BABA icon
5
Alibaba
BABA
$272B
$167M 1.85%
803,169
+9
+0% +$1.88K
BMY icon
6
Bristol-Myers Squibb
BMY
$126B
$157M 1.74%
2,498,798
+156
+0% +$9.54K
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$120B
$155M 1.72%
725,361
– –
REGN icon
8
Regeneron Pharmaceuticals
REGN
$68.2B
$151M 1.67%
411,216
+5
+0% +$2.06K
AMZN icon
9
Amazon
AMZN
$2.51T
$146M 1.61%
1,611,040
+40
+0% +$3.87K
GILD icon
10
Gilead Sciences
GILD
$162B
$143M 1.59%
2,256,997
+35
+0% +$2.42K
MRK icon
11
Merck
MRK
$322B
$124M 1.37%
1,460,538
+135
+0% +$10.6K
PG icon
12
Procter & Gamble
PG
$340B
$116M 1.29%
952,286
+35
+0% +$4.2K
BIIB icon
13
Biogen
BIIB
$29.7B
$114M 1.27%
394,265
– –
META icon
14
Meta Platforms (Facebook)
META
$1.54T
$112M 1.25%
560,116
+10
+0% +$1.96K
DIS icon
15
Walt Disney
DIS
$161B
$89.3M 0.99%
631,695
+51
+0% +$6.45K
TSM icon
16
TSMC
TSM
$2.15T
$82.5M 0.91%
1,453,137
+44
+0% +$2.41K
JPM icon
17
JPMorgan Chase
JPM
$927B
$76.6M 0.85%
562,170
+10
+0% +$1.22K
CSCO icon
18
Cisco
CSCO
$443B
$73M 0.81%
1,556,763
+94
+0% +$4.12K
ILMN icon
19
Illumina
ILMN
$29.7B
$72.3M 0.8%
229,282
+6
+0% +$1.68K
V icon
20
Visa
V
$666B
$70.7M 0.78%
384,963
+33
+0% +$6.22K
ABBV icon
21
AbbVie
ABBV
$452B
$64.2M 0.71%
742,021
– –
UNH icon
22
UnitedHealth
UNH
$385B
$63.7M 0.71%
221,657
+4
+0% +$1.1K
C icon
23
Citigroup
C
$222B
$63.6M 0.71%
814,820
+41
+0% +$2.75K
PEP icon
24
PepsiCo
PEP
$184B
$61.6M 0.68%
461,334
+25
+0% +$3.38K
ALXN
25
DELISTED
Alexion Pharmaceuticals
ALXN
$60.9M 0.67%
575,794
– –
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2020 Portfolio in Review

As of Q1 2020, Candriam SCA held 813 positions worth $9.02B, down 3.3% from $9.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2020 filing shows 30 new, 168 increased, 3 reduced and 20 closed positions. Its largest new stake was Hilton Worldwide: 116,476 shares worth $21.1M. The largest sale was Medicines Co, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2020 buy was Hilton Worldwide: 116,476 shares worth $21.1M.
  • Candriam SCA added most to Microsoft in Q1 2020, an estimated $13.8K increase.
  • Candriam SCA's biggest Q1 2020 reduction was Telus, cutting an estimated $1.67M.
  • Candriam SCA fully exited Medicines Co in Q1 2020, selling an estimated $13.3M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.02B portfolio in Q1 2020.
  • Candriam SCA opened 30 new positions and closed 20 in Q1 2020.
  • Candriam SCA's portfolio value fell 3.3% quarter-over-quarter to $9.02B.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.